LFMD Q2 2023 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q2 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$36M+18.0% YoY

Gross Profit

$31M87.3% margin

Operating Income

-$5M-13.6% margin

Net Income

-$7M-18.7% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+8.5%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$35M

Total Liabilities

$46M

Stockholders' Equity

-$11M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$30M	+18.0%
Gross Profit	$31M	$26M	+21.6%
Operating Income	-$5M	-$13M	+62.1%
Net Income	-$7M	-$13M	+48.3%